通过宏基因组学研究肠道微生物对结直肠癌患者影响的最新进展

doi:10.11904/j.issn.1002-3070.2020.01.018

Abstract

Abstract: Human gut microbes have received increasing attention in the medical community,and they have a great role not only in human health,but also in the occurrence and development of human diseases.The link between microbes and cancer,especially between the gut microbiota and intestinal tumors,is constantly being discovered.Metagenomics,as an important research method in microbial research,plays an increasingly important role in the study of microbial and colorectal cancer.In recent years,the study of gut microbiota by metagenomics has provided new insights into the development and progression of colorectal cancer,which emphasize the importance of host-microbe and microbial interactions in cancer microbiota.This article reviews the relationship between gut microbiota and colorectal cancer through metagenomics,and is expected to open up new opportunities for prevention,diagnosis and treatment of cancer.

Key words: Intestinal microbes, Colorectal cancer, Metagenomics

CLC Number:

R735.3

LI Zhijie, ZHAO Qi, WU Huaxing. Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics[J]. Journal of Practical Oncology, 2020, 34(1): 93-96.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.01.018

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I1/93

References

1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
2 Arnold M,Sierra MS,Laversanne M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66(4):683-691.
3 Picardo SL,Coburn B,Hansen AR.The microbiome and cancer for clinicians[J].Crit Rev Oncol Hematol,2019,141:1-12.
4 Handelsman J,Rondon MR,Brady SF,et al.Molecular biological access to the chemistry of unknown soil microbes:a new frontier for natural products[J].Chem Biol,1998,5(10):245-249.
5 李凤,李艳萍,张小蒙.宏基因组学的研究方法进展及应用概述[J].生物技术世界,2015,89(4):9-10.
6 Chiu CY,Miller SA.Clinical metagenomics[J].Nat Rev Genet,2019,20(6):341-355.
7 Chu DM,Seferovic M,Pace RM,et al.The microbiome in preterm birth[J].Best Pract Res Clin Obstet Gynaecol,2018,52:103-113.
8 熊晓平,陈修己,熊敦勇.胃癌及癌前病变中幽门螺杆菌与p53基因表达关系的研究[J].实用肿瘤学杂志,2003,17(3):84-186.
9 Grivennikov SI,Wang K,Mucida D,et al.Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth[J].Nature,2012,491(7423):254-258.
10 Chen J,Pitmon E,Wang K.Microbiome,inflammation and colorectal cancer[J].Semin Immunol,2017,32:43-53.
11 Karin M,Greten FR.NF-kappaB:linking inflammation and immunity to cancer development and progression[J].Nat Rev Immunol,2005,5(10):749-759.
12 Louis P,Hold GL,Flint HJ.The gut microbiota,bacterial metabolites and colorectal cancer[J].Nat Rev Microbiol,2014,12(10):661-672.
13 Almeida A,Mitchell AL,Boland M,et al.A new genomic blueprint of the human gut microbiota[J].Nature,2019,568(7753):499-504.
14 Qin J,Li R Raes J,et al. A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464:59-65.
15 Thomas AM,Manghi P,Asnicar F,et al.Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation[J].Nat Med,2019,25(4):667-678.
16 Dai Z,Coker OO,Nakatsu G,et al.Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers[J].Microbiome,2018,6(1):70.
17 Goodwin AC,Destefano Shields CE,Wu S,et al.Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis[J].Proc Natl Acad Sci U S A,2011,108(37):15354-15359.
18 Wu J,Li Q,Fu X.Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity[J].Transl Oncol,2019,12(6):846-851.
19 Ahn J,Sinha R,Pei Z,et al.Human gut microbiome and risk for colorectal cancer[J].J Natl Cancer Inst,2013,105(24):1907-1911.
20 Yu J,Feng Q,Wong SH,et al.Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer[J].Gut,2017,66(1):70-78.
21 Gur C,Ibrahim Y,Isaacson B,et al.Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J].Immunity,2015,42(2):344-355.
22 Whitmore SE,Lamont RJ.Oral bacteria and cancer[J].PLoS Pathogens,2014,10(3):e1003933.
23 Sender R,Fuchs S,Milo R,et al.Revised estimates for the number of human and bacteria cells in the body[J].PLoS Biol,2016,14(8):e1002533.
24 Richard ML,Sokol H.The gut mycobiota:insights into analysis,environmental interactions and role in gastrointestinal diseases[J].Nat Rev gastroenterol Hepatol,2019,16(6):331-345.
25 Luan C,Xie L,Yang X,et al.Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas[J].Sci Rep,2015,5(1):7980.
26 Nash AK,Auchtung TA,Wong MC,et al.The gut mycobiome of the Human Microbiome Project healthy cohort[J].Microbiome,2017,5(1):153.
27 Hallen-Adams HE,Kachman SD,Kim J,et al.Fungi inhabiting the healthy human gastrointestinal tract:a diverse and dynamic community[J].Fungal Ecol,2015,15:9-17.
28 Hallen-Adams HE,Suhr MJ.Fungi in the healthy human gastrointestinal tract[J].Virulence,2017,8(3):352-358.
29 Suhr MJ,Hallen-Adams HE.The human gut mycobiome:pitfalls and potentials-a mycologist′s perspective[J].Mycologia,2015,107(6):1057-1073.
30 Coker OO,Nakatsu G,Dai RZ,et al.Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer[J].Gut,2019,68(4):654-662.

[1]	ZENG Li, ZHUANG Shutong, DING Shihua, CHEN Chong, JIAO Lu, SUN Dayong. Molecular mechanisms of long non-coding RNA AFAP1-AS1 regulating the proliferation of colorectal cancer cells by PTEN/p-AKT signaling pathway [J]. Journal of Practical Oncology, 2020, 34(1): 11-16.
[2]	LIAO Daixiang, ZHENG Bo, ZHANG Yanbin, YU Junhui. Expression of RRBP1 and RABEX-5 proteins in colorectal cancer and their correlation with clinicopathological features and prognosis [J]. Journal of Practical Oncology, 2020, 34(1): 43-48.
[3]	ZHANG Jinglan, LIU Ruibao. Progress in local interventional therapy for colorectal cancer with liver metastasis [J]. Journal of Practical Oncology, 2020, 34(1): 79-82.
[4]	ZHANG Yiwei, SHI Jing, LIU Yupeng, CAO Liming, HU Fulan, ZHAO Yashuang. Relationship between methylation of USP1 gene in peripheral blood and prognosis risk of colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(5): 420-424.
[5]	PU Rui, ZHU Lin, XIA Tingting, BI Haoran, SUN Hongru, HUANG Hao, ZHANG Lei, ZHAO Yashuang. Relationship between the methylation status of CpG island in STAT1,STAT3 gene promoters in peripheral blood and prognosis of colorectal cancer [J]. Journal of Practical Oncology, 2019, 33(4): 346-351.
[6]	FANG Xuan, CHEN Hongsheng, Li Guodong, LIU Ming. Advances in research on treatment of aberrant crypt foci [J]. Journal of Practical Oncology, 2019, 33(4): 376-379.
[7]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[8]	TONG Guanghai, TIAN Yang, WU Huaxing. Application of lipidomics in colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 179-192.
[9]	LIU Hengchen, ZHANG Xinyu. Toll-like receptor signaling pathway as a potential therapeutic target for colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 188-192.
[10]	LIU Hongtao, ZHANG Tongtong, LIU Yanjun. Research progress in the pathogenesis of obesity and colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 464-467.
[11]	WANG Zhi,LIU Zhongwei,ZENG Xueyun,SUI Mingjie,LIAO Jingyi,LI Yuehuan,HUANG Weidong,LIU Guoxiang. Health-related quality of life in patients with colorectal cancer precancerous lesions on EQ-5D-5L [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 320-326.
[12]	CUI Xueyang,XING Chengzhong. The research and application of liquid biopsy in the field of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 367-370.
[13]	LI Wenqi,GENG Jingshu. Research progress of RAS,RAF mutation and MSI status in the treatment of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 371-376.
[14]	LV Qiang, CHEN Hongsheng, LI Guodong, WEI Jiufeng, LIU Ming. Effects of tumor-associated fibroblasts in the development of colorectal cancer and its research progress [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 275-279.
[15]	ZHANG Shanshan, WU Huaxing. Aplication of metabolomics in the diagnosis of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 573-576.

Research progress in the effects of intestinal microbes on colorectal cancer patients by metagenomics

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments